Analyst Price Targets — TRNS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 23, 2025 12:40 pm | Ted Jackson | Northland Securities | $95.00 | $76.99 | TheFly | Transcat upgraded to Outperform from Market Perform at Northland |
| October 30, 2024 9:03 am | Greg Palm | Craig-Hallum | $113.00 | $98.84 | TheFly | Transcat price target lowered to $113 from $138 at Craig-Hallum |
| October 30, 2024 8:45 am | Ted Jackson | Northland Securities | $110.00 | $98.84 | TheFly | Transcat price target lowered to $110 from $130 at Northland |
| October 29, 2024 7:26 am | Scott Buck | H.C. Wainwright | $156.00 | $104.18 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Transcat Inc. (TRNS) |
| July 31, 2024 9:03 am | Greg Palm | Craig-Hallum | $138.00 | $116.91 | TheFly | Transcat price target lowered to $138 from $150 at Craig-Hallum |
| May 22, 2024 5:33 am | Martin Yang | Oppenheimer | $160.00 | $141.86 | StreetInsider | Transcat Inc. (TRNS) PT Raised to $160 at Oppenheimer |
| April 18, 2024 7:26 am | Martin Yang | Oppenheimer | $125.00 | $104.71 | StreetInsider | Transcat Inc. (TRNS) PT Raised to $125 at Oppenheimer |
| February 2, 2023 9:04 am | — | Roth Capital | $94.00 | $84.87 | Benzinga | Roth Capital Maintains Buy on Transcat, Raises Price Target to $94 |
| February 1, 2023 10:00 am | — | Northland Securities | $100.00 | $85.69 | Benzinga | Northland Capital Markets Maintains Outperform on Transcat, Raises Price Target to $100 |
| February 1, 2023 9:41 am | — | Craig-Hallum | $92.00 | $85.65 | Benzinga | Craig-Hallum Maintains Buy on Transcat, Raises Price Target to $92 |
Latest News for TRNS
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical.
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September.
Dimensional Fund Advisors LP grew its position in Transcat, Inc. (NASDAQ: TRNS) by 3.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 262,033 shares of the scientific and technical instruments company's stock after purchasing an additional 9,266 shares during the
Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript
Transcat NASDAQ: TRNS reported first-quarter fiscal 2027 revenue of $92.9 million, up 22% from a year earlier, as both its calibration services and distribution segments posted double-digit growth. The company said demand remained strong across its regulated end markets, including life sciences, aerospace and defense, and energy.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for TRNS.
U.S. House Trading
No House trades found for TRNS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.